Advances in Immunology, Volume 166, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Series Page - p. iii 5. Copyright - p. iv 6. Contributors - p. xi 7. Chapter One: Harnessing the immune system: Insights into cancer vaccines - p. 1 8. Chapter Two: Lipid nanoparticle mediated mRNA delivery in cancer immunotherapy - p. 37 9. Chapter Three: Nanoparticles for mRNA-based cancer immunotherapy - p. 77 10. Chapter Four: B-cell editing: An emerging alternative of precision oncotherapy - p. 103 11. Chapter Five: Personalized precision: Revolutionizing cancer treatment with mRNA-based vaccines in melanoma therapy - p. 137 12. Chapter Six: Revolutionizing cancer treatment: Exploring novel immunotherapeutics, checkpoints, bispecifics, and vaccines in development - p. 169 13. Chapter Seven: Recent progress, challenges (stability and in vivo distribution), and opportunities of DNA & mRNA vaccine in cancer immunotherapy - p. 211
Advances in Immunology, Volume 166, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Series Page - p. iii 5. Copyright - p. iv 6. Contributors - p. xi 7. Chapter One: Harnessing the immune system: Insights into cancer vaccines - p. 1 8. Chapter Two: Lipid nanoparticle mediated mRNA delivery in cancer immunotherapy - p. 37 9. Chapter Three: Nanoparticles for mRNA-based cancer immunotherapy - p. 77 10. Chapter Four: B-cell editing: An emerging alternative of precision oncotherapy - p. 103 11. Chapter Five: Personalized precision: Revolutionizing cancer treatment with mRNA-based vaccines in melanoma therapy - p. 137 12. Chapter Six: Revolutionizing cancer treatment: Exploring novel immunotherapeutics, checkpoints, bispecifics, and vaccines in development - p. 169 13. Chapter Seven: Recent progress, challenges (stability and in vivo distribution), and opportunities of DNA & mRNA vaccine in cancer immunotherapy - p. 211
